Metabotropic Glutamate Receptors and Baroreceptor Input

代谢型谷氨酸受体和压力感受器输入

基本信息

  • 批准号:
    7390780
  • 负责人:
  • 金额:
    $ 21.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-08-14 至 2008-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The nucleus tractus solitarius (NTS) is a key regulatory moment in baroreceptor reflex control of blood pressure. The baroreceptor signals are transmitted from the primary fibers to the second-order NTS neurons by glutamate acting at ionotropic glutamate receptors, but it is the balance of inhibitory and excitatory mechanisms modulating this transmission that determines the NTS output, which in turn, orchestrates reflex output. The metabotropic glutamate receptors (mGluRs) have expanded the classic neurotransmitter role of glutamate to an extensive neuromodulator role by allowing it to regulate it's own signaling through comprehensive presynaptic and postsynaptic mechanisms. Our long-term goal is to characterize how and when mGluRs shape NTS output of baroreceptor signals acutely and long-term. In our parent grant, we showed that glutamate released during high frequency baroreceptor firing activated presynaptic mGluRs on the central terminals to decrease glutamate release, precisely regulating the amount reaching the second-order neurons. This renewal features new findings on presynaptic and postsynaptic mGluR effects: 1) glutamate released during high-frequency baroreceptor firing reaches presynaptic mGluRs on nearby GABA terminals to depress GABA release, thereby depressing both GABA and glutamate release at the second-order neurons; 2) presynaptic mGluRs induce long-term (1 hr) changes in GABA release, a promising mechanism for long-term regulation; 3) postsynaptic mGluR activation is voltage dependent, suggesting that the neuronal excitability specifies the postsynaptic mGluR contribution to baroreceptor signaling; and 4) postsynaptic mGluR-induced increases in neuronal excitability may be mediated via several ionic currents, providing new potential regulatory sites. Building on these data, we developed six Aims, to test the Hypotheses that: 1. presynaptic mGluRs modulate baroreceptor signal transmission at NTS baroreceptor synapses by inhibiting both glutamate and GABA release onto second-order NTS baroreceptor neurons, a modulation that exerts both short- and long-term effects on synaptic excitability (Aims 1-3); and 2. postsynaptic mGluRs on these same neurons, by modulating multiple ionic currents, integrate the intrinsic excitability with synaptic excitability to shape short- and long-term baroreceptor signaling (Aims 4-6). The Aims will be achieved by using patch-clamp analysis to isolate presynaptic and postsynaptic mGluR effects on anatomically- and electrophysiologically-identified baroreceptor second-order NTS neurons in a slice. Understanding precisely how and when mGluRs modulate synaptic and intrinsic excitability at these NTS synapses will provide new mechanisms for the acute and long-term regulation of baroreceptor signaling and hence baroreflex function.
描述(由申请人提供):孤束核(NTS)是压力感受器反射控制血压的关键调节时刻。压力感受器信号通过作用于离子型谷氨酸受体的谷氨酸从初级纤维传递到二级NTS神经元,但调节这种传递的抑制和兴奋机制的平衡决定了NTS输出,反过来,协调反射输出。代谢型谷氨酸受体(mGluRs)通过允许谷氨酸通过全面的突触前和突触后机制调节其自身的信号传导,将谷氨酸的经典神经递质作用扩展为广泛的神经调节剂作用。我们的长期目标是表征mGluRs如何以及何时形成NTS压力感受器信号的急性和长期输出。在我们的研究中,我们发现在高频率压力感受器放电过程中释放的谷氨酸激活了中枢末梢上的突触前mGluRs,以减少谷氨酸的释放,精确地调节到达二级神经元的量。这一更新的特点是对突触前和突触后mGluR效应的新发现:1)在高频压力感受器放电过程中释放的谷氨酸到达突触前mGluR附近的GABA终末以抑制GABA释放,从而抑制二级神经元的GABA和谷氨酸释放; 2)突触前mGluR诱导GABA释放的长期(1小时)变化,这是一种有希望的长期调节机制; 3)突触后mGluR激活是电压依赖性的,表明神经元兴奋性指定突触后mGluR对压力感受器信号传导的贡献;和4)突触后mGluR诱导的神经元兴奋性增加可以通过几种离子电流介导,提供新的潜在调节位点。在这些数据的基础上,我们开发了六个目标,以验证假设:1。突触前mGluR通过抑制谷氨酸和GABA释放到二级NTS压力感受器神经元上来调节NTS压力感受器突触处的压力感受器信号传递,这是一种对突触兴奋性发挥短期和长期作用的调节(目的1-3);和2.通过调节多个离子电流,这些相同神经元上的突触后mGluR整合内在兴奋性与突触兴奋性以形成短期和长期压力感受器信号传导(目的4-6)。这些目标将通过使用膜片钳分析来分离突触前和突触后mGluR对切片中解剖学和电生理学鉴定的压力感受器二级NTS神经元的影响来实现。精确地了解mGluRs如何以及何时调节这些NTS突触的突触和内在兴奋性,将为压力感受器信号传导的急性和长期调节以及压力反射功能提供新的机制。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A novel postsynaptic group II metabotropic glutamate receptor role in modulating baroreceptor signal transmission.
Group I metabotropic glutamate receptors on second-order baroreceptor neurons are tonically activated and induce a Na+-Ca2+ exchange current.
二阶压力感受器神经元上的 I 类代谢型谷氨酸受体被强直激活并诱导 Na -Ca2 交换电流。
  • DOI:
    10.1152/jn.00772.2005
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Sekizawa,Shin-ichi;Bonham,AnnC
  • 通讯作者:
    Bonham,AnnC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANN C. BONHAM其他文献

ANN C. BONHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANN C. BONHAM', 18)}}的其他基金

Post-Exercise Hypotension: Central Sites and Mechanisms
运动后低血压:中枢部位和机制
  • 批准号:
    6637546
  • 财政年份:
    2001
  • 资助金额:
    $ 21.12万
  • 项目类别:
Post-Exercise Hypotension: Central Sites and Mechanisms
运动后低血压:中枢部位和机制
  • 批准号:
    6703709
  • 财政年份:
    2001
  • 资助金额:
    $ 21.12万
  • 项目类别:
Post-Exercise Hypotension: Central Sites and Mechanisms
运动后低血压:中枢部位和机制
  • 批准号:
    6530761
  • 财政年份:
    2001
  • 资助金额:
    $ 21.12万
  • 项目类别:
Post-Exercise Hypotension: Central Sites and Mechanisms
运动后低血压:中枢部位和机制
  • 批准号:
    6317287
  • 财政年份:
    2001
  • 资助金额:
    $ 21.12万
  • 项目类别:
Post-Exercise Hypotension: Central Sites and Mechanisms
运动后低血压:中枢部位和机制
  • 批准号:
    6857060
  • 财政年份:
    2001
  • 资助金额:
    $ 21.12万
  • 项目类别:
AREA POSTREMA MODULATION OF AFFERENT INPUT FROM BARORECEPTOR AND ATRIAL RECEPTORS
来自压力感受器和心房感受器的传入输入的后区调制
  • 批准号:
    6202377
  • 财政年份:
    1999
  • 资助金额:
    $ 21.12万
  • 项目类别:
CORE--BIOENGINEERING AND HISTOLOGY
核心--生物工程和组织学
  • 批准号:
    6202382
  • 财政年份:
    1999
  • 资助金额:
    $ 21.12万
  • 项目类别:
CORE--BIOENGINEERING AND HISTOLOGY
核心--生物工程和组织学
  • 批准号:
    6110342
  • 财政年份:
    1998
  • 资助金额:
    $ 21.12万
  • 项目类别:
Metabotropic Glutamate Receptors and Baroreceptor Input
代谢型谷氨酸受体和压力感受器输入
  • 批准号:
    6727135
  • 财政年份:
    1998
  • 资助金额:
    $ 21.12万
  • 项目类别:
Metabotropic Glutamate Receptors and Baroreceptor Input
代谢型谷氨酸受体和压力感受器输入
  • 批准号:
    6845970
  • 财政年份:
    1998
  • 资助金额:
    $ 21.12万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 21.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 21.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 21.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了